Study of effect of subcutaneous enoxaparin sodium injection duration on incidence and extent of bruising at injection site in hospitalized patients.
Not Applicable
- Conditions
- ?Bruising in site of enixaparin sodium injection.Hemorrhage in any site resulting from a procedure
- Registration Number
- IRCT2015032721547N1
- Lead Sponsor
- Social determinants of health research center, Guilan university of medical sciences, Rasht, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
Patients being in the first 24 hours of hospitalization in cardiac care unit who need to remain hospitalized for at least another 48 hours; coagulation tests results within therapeutic range; written order for subcutaneous 6000 IU enoxaparin sodium in patients`record; no special treatments required (fibrinolytic therapy, angioplasty,...), widespread skin lesions on the right side of the abdomen or any blood and liver diseases and signing written consent form to participate in the study.
Exclusion criteria: Any changes in drug order or dosage, discharge before data selection time duration and death of a patient .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of bruising in site of enoxaparin sodium injection. Timepoint: 48 hours after intervention. Method of measurement: Recording the observed bruising in prepared form.;The extent of bruising in area of Enoxaparin sodium in Milimeter. Timepoint: 48 hours after intervention. Method of measurement: Recording the bruising extent (by flexible ruler in milimeter) in prepared form.
- Secondary Outcome Measures
Name Time Method